Author | Cristiana Sessa, MD | OncLive

Author | Cristiana Sessa, MD

Articles

Dr. Sessa on the Management of BRCA1/2 Mutations in Ovarian Cancer

January 11, 2018

Video

Cristiana Sessa, MD, head of Phase I-II Unit and Pharmacology, vice head of Medical Oncology and Head of Clinical Research, Oncology Institute of Southern Switzerland, discusses the management of BRCA1/2 mutations in patients with ovarian cancer.

Dr. Sessa Discusses ATR Inhibitors in BRCA-Mutated Tumors

November 08, 2017

Video

Cristiana Sessa, MD, head of Phase I-II Unit and Pharmacology, vice head of Medical Oncology and Head of Clinical Research, Oncology Institute of Southern Switzerland, discusses ataxia–telangiectasia and Rad3 related (ATR) inhibitors in patients with ovarian cancer who have BRCA-mutated tumors.

x